70 results about "Oral infection" patented technology

This invention concerns a method of making an anti-infective composition for oral administration using an agent selected from the group consisting of lactoferrin protein and lysozyme protein. The method comprises three steps. The nucleic acid, which encodes a lactoferrin or lysozyme protein, is expressed in a monocot seed. The protein is isolated from the seed. This protein isolation compromises greater than 3% of the total soluble protein in the monocot seed. The protein is then formulated for oral administration.

The invention relates to the technical field of antibacterial liquids, and particularly relates to a medical antibacterial liquid and a preparation method thereof. Each liter of antibacterial liquid is prepared from the following materials: 1.7-1.9g of dialkyl quaternary ammonium salt, 30-50ml of glycerol, 0.1-1.3g of menthol, 3-20ml of ethanol, 3-6g of traditional Chinese medicine extract, and the balance of purified water. The materials of the medical antibacterial liquid are in supplement with each other and play the synergistic action; and the traditional Chinese medicine extract contains a plurality of antiphlogistic, antibacterial and analgesic components, so that the antibacterial property achieves the optimal extent. The biocompatibility of the medical antibacterial liquid accords with the requirements of GB / T16886.11-2011; and a microbiological indicator accords with the requirements of GB15979-2002. The medical antibacterial liquid is suitable for nursing of small-area skin and oral infection, burns and scalds, wound infection, vaginal infection, anus infection and mucosal wound infection, nursing of the newborn skin and umbilical region, and nursing of postpartum genital and wound infection; wound healing is facilitated; and postoperative infection is also reduced.

The invention discloses a collutory with bacterial-resisting, inflammation-eliminating and deodorizing functions and a preparation method and use of the collutory. The collutory is prepared from principal raw materials such as a pomegranate bark extract, roses and calyx seu fructus physalis in combination with a humectant, a sweetening agent, a preservative and distilled water. The collutory can form an obstacle on the surfaces of the teeth due to joint effect of the effective components, so that bacteria are hardly attached to the surfaces of the teeth and bacteria attached to the surfaces of the teeth to cause bacterial plaque are reduced, thereby keeping the oral cavity clean and eliminating odor of the oral cavity. The collutory can be used for preventing or treating gingivitis, periodontitis, dental ulcers and oral and throat inflammations. Meanwhile, the collutory can eliminate ozostomia and maintain fresh breath, and not only can be used for adjuvant therapy of oral inflammations, but also can be used for daily oral health. The collutory used for a long time is free of any side effects. When in use, the product used not only facilitates movement of muscles around the oral cavity by means of the mouthwash movement, but also promotes the self-cleaning effect of the oral cavity, so that the collutory is the best option for maintaining oral hygiene and preventing oral infection.

The present invention concerns a disinfectant or antimicrobial composition for use in dental treatment, such as treatment and / or prevention of periodontitis, gingivitis or other forms of oral infection. The present Inventor found that microorganisms that infect the dental tissues and cause inflammation thereof, are susceptible to osmotic stress, to such extent that the application of a hypertonic composition is effective in curing or preventing infection and / or inflammations. It was furthermore found that these microorganisms are also susceptible to acidic stress. The present invention therefore provides compositions that induce osmotic stress in microorganisms causing infection of dental tissue when topically applied thereto, preferably osmotic as well as acidic stress. The present invention also concerns the methods and uses involving the compositions of the invention.

The invention relates to a biologic active mineral powder chewing gum and a preparation method thereof. The biologic active mineral powder chewing gum comprises the following components in parts by weight: 20-95 parts of gum bases, 3-50 parts of biologic active mineral powder, 0.03-15 parts of carbonate, 0.03-15 parts of phosphate, 0-30 parts of calcium carbonate, 1-30 parts of a sweetening agent, and 1-25 parts of a flavoring agent, wherein the biologic active mineral powder comprises the following substances in percentage by weight: 30-55% of SiO2, 10-35% of CaO, 10-35% of Na2O, 2-10% of P2O5, and 0-15% of K2O. The biologic active mineral powder in the chewing gum disclosed by the invention can inhibit and kill various bacteria in oral cavities, so that oral cavity problems, such as oral infection, dental ulcer and gingivitis, can be prevented and cured, and besides, through the remineralization of the biologic active mineral powder on teeth, the dentin coloboma can be effectively repaired.

The invention discloses a preparation method and applications of gastric floating tablets containing ornidazole, belonging to a novel technical field of medicament and relating to a novel medicament form of ornidazole. 1. The gastric floating tablets are used to treat a plurality of diseases caused by bacteroides fragilis, bacteroides distasonis, bacteroides oval window, etc.; (2) oral cavity infections: pericoronitis, periapical periodontitis, pericoronitis, acute ulcerouse gingivitis etc.; (3) gynae infections: endometritis, myometritis, oviduct or ovarian abscess, pelvic cavity soft tissue infection, haemophilis vaginitis etc.; (4) surgical infections: wound infection, abscess of epidermis, bedsore ulcerouse infection, cellulites, gas gangrene etc.; (5) brain infections: meningitis, brain abscess; (6) septicaemia and severe general infections etc. 2. The gastric floating tablets are used to prevent infections before an operation and treat anaerobic infections after an operation. 3. The gastric floating tablets are used to treat urogenital canal trichomonas and giardia lamblia infections, such as trichomoniasis etc. 4. The gastric floating tablets are used to treat alimentary system amebiasis, such as amebic dysentery, amoebic liver abscess etc. The new medicament form is characterized in that the surface thereof is hydrated into gel after contacting with gastric juice at body temperature so as to cause volume expansion because the gastric floating tablets contain a plurality of hydrophilic macromolecule materials. Weight of the tablets is less than floating force of the gastric juice, so the tablets float on the gastric juice so as to prolong time in a stomach.

A method of preventing or treating an oral disease by reducing adhesion of microorganisms, e.g. Candida albicans, to dental appliances fabricated and / or repaired by an autopolymerizing acrylic reinforcement resin comprising zirconium dioxide nanoparticles.

Provided are compositions and devices containing microspheres encapsulating one or more drug(s). The compositions and devices may be used to treat or prevent infection associated or caused by oral mucosal diseases, oral infections, oral conditions, dental conditions, or surgical recovery. The devices include, but are not limited to, splints, mouth guards, full dentures, partial dentures, or fillings. The devices may be manufactured from filaments that have a composition of the present disclosure. Also provided are methods of making and using the devices and compositions.

The invention relates to the compounds or its pharmaceutical acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, formula II, formula III, formula IV, formula V, formula VI, formula VII, formula VIII, formula IX, formula X, formula XI and formula XII and, the methods for the treatment of oral infectious diseases may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer tablet, parenteral administration, syrup, or injection. Such compositions may be used to treatment of oral infectious diseases.

The application provides a compound probiotic lactic acid bacteria powder and its preparation method and application. The compound probiotic lactic acid bacteria powder is composed of Lactobacillus casei bacteria powder, Bifidobacterium animal V9 bacteria powder, Lactobacillus plantarum P‑8 bacteria powder, Lactobacillus plantarum C2 bacteria powder is compounded with prebiotics and fruit and vegetable powder. Compound probiotic lactic acid bacteria powder has a significant protective effect on irritable bowel syndrome, oral infection and nasal infection, and has a significant preventive effect on upper respiratory tract infection. At the same time, it can improve gastrointestinal symptoms, regulate intestinal flora, and improve the body's immunity .